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All of the immune functions that are mediated by thymus-derived lympho- 
cytes (T cells)  are associated with cell surface structures coded by the major 
murine histocompatibility gene complex (H-2). Two main subgroups of T cells 
can be distinguished with respect to: (a) function, (b) nature of the antigen they 
are specific  for,  (c) the H-2  subregion coding for the self-cell surface marker 
which is involved in defining the T-cell specificity, and (d) the Ly cell surface 
marker. Thus, "helper" T cells reactive to chemically and/or biologically inert 
antigens  (1), which functionally associate in  as yet unexplained ways with 
structures coded in the I  region (2-7),  possess  the Ly 1, but not the Ly 2 or 3 
markers (8, 9). In contrast, "cytolytic"  T cells, specific for viral antigens (6, 7, 10, 
11), chemically reactive antigens (12), or alloantigens, (12-14) which associate 
functionally with the H-2K and H-2D structures, have the Ly 2,3 marker (8, 9). 
Listeria  monocytogenes,  a  facultative intracellular bacterium, triggers  in 
mice a strong virtually exclusive cell-mediated immune response as has been 
classically described by Mackaness (15-17), Lane and Unanue (18), Blanden and 
Langman (19), and North (20). The adoptive transfer of this T-cell-mediated 
immunity was previously shown to be restricted by the H-2 gene complex (21). 
This result was the first experimental evidence for speculations of Mitchison (22) 
and Lawrence (23) made on delayed-type  hypersensitivity to tuberculin some 20 
yr ago; namely, that cell-mediated immunity was reactive to bacterial antigen 
only when presented on cell surfaces. Particularly the self-plus X hypothesis of 
Lawrence pre-empted some of the current ideas that attempt to explain the H-2 
restriction of cellular immunity to viruses, intracellular bacteria,  and inert, 
conventional antigens (23). L. monocytogenes, like viruses, fall into the category 
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of infectious multiplying agents; however, they do not seem to trigger cytotoxic 
T  cells demonstrable in vitro.  Instead,  Listeria  infection sensitizes  specific T 
cells which in vivo activate macrophages to nonspecifically increased bacteri- 
cidal capacity. 
In this study the effector T cells involved in Listeria infections were character- 
ized with respect to the H-2  region involved  in defining the specificity.  The 
results indicate that Listeria-immune  effector T cells are,  in addition to their 
specificity  for Listeria,  specific for cell  surface  self-structures  coded in the I 
region  of H-2.  They  support the hypothesis  that the various H-2-coded self- 
markers are on-off switches that are operated by specific T cells for triggering 
differentiation of distinct, partially cell-specific functions. 
Materials and Methods 
Mice.  CBA/H, BALB/c, C57BL/6,  C3H/St,  SJL, B10.BR, B10.A(3R), B6-H-2 b a (Hzl), B6-H-2 bf 
(Hzl70)  were  purchased  from  The  Jackson  Laboratory,  Bar  Harbor,  Maine  and  The  Strong 
Foundation, San Diego, Calif. or bred at the Australian National University. C3H.OH and A.TL 
(24,  25) were from colonies originating from the Department of Human Genetics, University of 
Michigan Medical School, Ann Arbor, Mich. 
Bacteria.  The strain ofL. monocytogenes used and preparation of bacterial inocula have been 
described elsewhere (19).  For intravenous (i.v.) injections the lethal dose for 50% of the animals 
(LDso) was approximately 5 x  104 for C57BL, 2 x  104 for BALB/c and CBA/H, and 2 x  103 for A.TL 
and SJL. The methods for enumeration of viable bacteria in individual mouse spleens have been 
described by Mackaness (15-17). 
Adoptive  Transfer  of Antibacterial  Protection.  The  protocol  of Mackaness  was  used  with 
modifications (17).  Briefly, mice were immunized i.v. with about 1/4 of an LDso and sacrificed by 
cervical dislocation 6-7 days later. Single cell suspensions were made from their spleen cells (19). 
Recipients were injected usually with 5 x  103L. monocytogenes 2-4 h after which 3-6 x  107 viable 
spleen cells were transferred i.v. into the infected animals. Viable bacteria were determined 24 h 
later (21). 
Preparative Separation of Ig-Positive and Ig-Negative Lymphocytes.  The method of Parish et 
al.  (26) was used exactly as described. The reagents were generously provided by Dr. C.  Parish, 
Australian National University, Canberra, Australia. Briefly, sheep IgG specific for rabbit Ig was 
coupled to sheep red cells (SRBC) by CrC13 treatment. These SRBC were then used to form rosettes 
which had been pretreated with hyperimmune rabbit anti-mouse Ig serum. Rosettes were sepa- 
rated from non-Ig-bearing cells by centrifugation through Isepaque/Ficoll. Ig-bearing cells were 
freed of SRBC by transient hypotonicity. After separation the Ig-positive and Ig-negative lympho- 
cyte population was transferred in numbers that corresponded to the percentage of total spleen 
cells they represented before separation. 
Mixed Lymphocyte Cultures (MLC).~  Primary alloreactive cytotoxic T cells were generated in 
vitro as described by Lafferty et al. (27). The cytotoxic activity of these MLC cells was monitored in 
a 51Cr-release assay as described by Cerottini and Brunner (28). The percentage of blast-like cells 
in the CBA/H anti-BALB/c cultures was 45% as compared to 15% in the control CBA/H anti-CBA/ 
H  cultures. 
Anti-Sera  Treatment.  AKR  anti-0  C3H  was  purchased  from  Bionetics,  Kensington,  Md. 
(catalogue no. 8301-01,  lot no. 231-61-5).  It was used at a  1:10 dilution and incubated with 5  x  107 
spleen cells/ml for 30 rain at 4°C and for 30 rain at 37°C with a selected rabbit complement (C) at a 
final dilution of 1:8. This treatment lysed 45% of the spleen cells specifically. The same conditions 
caused complete abolition of virus-specific cytotoxic activity as tested in a  5~Cr-release assay in 
vitro (1). 
Selective Proliferation Experiments In Vivo.  7-day immune spleen cells (1 x  108) from CBA/H 
x  C57BL/6 F1 were transferred into parental type recipients (P) which were lethally irradiated 
1  Abbreviations used in  this paper:  LCMV,  lymphocytic choriomeningitis virus; MLC,  mixed 
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(850 rads) 6 h before,  and dosed i.v.  with 5 x  103 viable bacteria 3 h before cell  transfer.  The 
recipients  were given 3 mg of  ampicillin (Beecham Research Laboratories, England) intraperito- 
neaUy after  2 days. The spleens were removed on the 3rd day, and single  cell  suspensions were 
cultured (2 × 10  s  cells/100  ml Eagle's minimal essential  medium supplemented with bicarbonate, 
100 ~tg  penicillin  streptomycin, and 10% fetal  calf  serum in 250-mi plastic  Falcon tissue  culture 
flasks)  for 24 h in the presence of  antibiotics  to remove the majority of  living  bacteria (29).  The 
surviving 50-70% of the cells  were passed through cotton wool, washed in medium  without 
antibiotics  for  2  h at  37°C,  and injected  i.v.  into  parental recipients  at  5 × 107  viable  cells/0.4  ml. 
Statistical  Methods.  The significance  of the difference  between means was assessed using 
Student's  t  test.  When immune protection  against  Listeria  is  studied  by  using  infectious  doses well 
below the LDso, the murine Listeria model is sensitive,  relatively  well defined, and yields 
reproducible results.  Therefore, differences  between experimental and control  groups may reach 
statistically  significant  levels  without representing biologically  significant  protection. 
Results 
Identity  of H-2-Restricted  Effector Lymphocytes.  From  the  first  report  of 
restriction of the adoptive transfer of immunity to Listeria it was obvious that 
this H-2 restriction was less absolute than in the virus models and that it was 
more obviously cell-dose dependent.  To determine whether the protection con- 
ferred by transfers of allogeneic Listeria-immune spleen cells was from T cells or 
non-T  cells,  Ig-positive  and  Ig-negative  Listeria-immune  lymphocytes  were 
assayed for their protective potential  (Fig.  1). 
Ig-negative lymphocytes transferred  about 2 loglo of protection measured as 
the difference of viable counts per spleen in experimental  groups as compared 
with  control  groups  receiving  no  cells.  At  the  doses tested  the  Ig-negative 
lymphocytes were absolutely restricted  to  operate  optimally  only in  the H-2 
compatible recipient. The Ig-positive cell fraction conferred a much lower degree 
of 0.2-0.8 loglo of protection which was significant only in some combinations. 
However, this protective capacity was not H-2 restricted. Therefore, the Liste- 
ria-specific  T-cell-mediated  protection  appears  to  be T-cell-mediated  and  re- 
stricted by the H-2 gene complex probably to a similar extent as has been shown 
for virus-specific T-cell-mediated anti-viral  protection in vivo and in vitro  (30, 
31). 
To investigate the possibility that any, i.e.  also allogeneic,  activated T cells 
could be recruited in relatively great numbers into infectious lesions and thus 
cause  non-H-2-restricted  anti-Listeria  protection,  MLC  allogeneically  stimu- 
lated lymphocytes were transferred  to Listeria-infected recipients.  To imitate 
the allogeneic donor-recipient combination, CBA/H (H-2 k) anti-BALB/c (H-2 d). 
sensitized  MLC cells  (3  ×  107 per recipient)  that  were highly  active in  slCr- 
release  assays  were  transferred  to  Listeria-infected  C57BL/6  recipients.  No 
significant protection was detectable. Therefore, if nonspecific T cells could have 
been recruited preferentially to infectious and inflammatory lesions, they were 
unable  to act upon macrophages  directly or via lymphokines  to increase  the 
latter's anti-bacterial  activity.  Also, anti-0 and C-treated immune spleen cells 
are able to transfer 0.5-0.7 log10 of protection as demonstrated by Blanden and 
Langman  (19) or North (20). 
Demonstration of  H-2 Restriction Depends Upon Relative Listeria-Specific T- 
Cell Activity of Spleen Cells.  The capacity of 5  x  107 spleen cells to transfer 
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Fro.  1.  H-2  restriction  of the  anti-Listeria  activity  of surface  Ig-negative  lymphocytes 
assayed in an adoptive transfer system. Donor mice were infected with approximately 5  × 
103 Listeria 6 day previous to cell harvest. Ig-negative spleen cells were separated from Ig- 
positive  ones by the method of Parish et al.  (26).  The numbers of transferred  separated 
spleen cells corresponded approximately to the relative numbers before separation. Recipi- 
ent mice  were  injected with about 6  x  103 Listeria  2  h  previous  to  cell  transfer.  Viable 
bacteria counts were determined 24 h  later. Means  -+ SEM of groups of three to five mice 
were compared statistically: group 3 vs. groups 7 or 8: not significant (NS); 3 vs. 1, 5, 10,  12, 
14: P  <  0.001; 4 vs. 6: NS, 4 vs. 9: P  <  0.01;  10 vs. 12,  14: P  <  0.01; i  vs. 12: NS; 1 vs.  14: P  < 
0.05;  11 vs.  2, 4, 6, 9,  13: P  <  0.001;  11 vs.  15: NS. 
specific  activity.  In  Table  I,  one  example  of many,  spleen  cells  of CBA/H- 
immune donors which are poorly active in syngeneic recipients  transfer about 
the  same  level  of protection  to allogeneic  recipients.  BALB/c-immune  spleen 
cells of great syngeneic  activity,  transfer to allogeneic CBA/H again the same 
background  protection  of about 0.6-1.0  loglo  (Table  I).  Thus,  under  standard 
experimental conditions only spleen cell populations that confer greater than 1 
loglo of protection will allow specific H-2 restriction to be measured reliably. 
Genetic  Mapping  of the H-2 Regions Involved  in Defining  T-Cell Specific- 
ity.  Three sets of experiments attempted to evaluate whether compatibility at: 
(a) the D  or K  region of H-2  alone,  or (b) the I  region alone was sufficient to 
transfer maximal protection, and (c) whether wild-type H-2K b Listeria-immune 
spleen cells were able to transfer protection to H-2K b  a or H-2K  bf mutant mice. 
Tables II and III and Fig.  2 indicate  that H-2 compatibility between donors 
and recipients at the K  end results in much more efficient transfer of protection 
than if the D  end is shared.  B10.A-immune  spleen cells protect CBA/H recipi- 
ents and B10.BR lymphocytes protect B10.A recipients each by more than 3 log~o 
(P  <  0.00001) as efficiently  as fully syngeneic  combinations  (Table II,  Fig.  2). ZINKERNAGEL ET AL.  1357 
TABLE  I 
Relative Independence from Specific Anti-Listeria  Activity of Non-H-2-Restricted 
Background Protection by Unseparated Immune Spleen Cells 
Donors  of immune* 
spleen  cells 
Loglo Listeria$ 
Protection  Protection 
Per  CBA/H  spleen  vs.  control  Per  BALB/c  spleen  vs.  control 
Listeria  immune 
CBA/H  4,95  ±  0.23§,11  1.09  5,10  ±  0.15  0.76 
BALB/c  5.09  ±  0.33  0.95  3,47  ___  0.23¶  2.39 
Normal  CBA/H  5.75  ±  0.15  0.29  5.65  ±  0.10  0.21 
Normal  BALB/c  5,79  ±  0.17  0.25  5.58  ±  0.16  0.26 
Control  (no cells)  6.04  ±  0.12  5.86  ±  0.15 
*  Donor  mice  were  infected  with  about  3  ×  10  s Listeria  6  days  previous  to assay. 
$  Viable  counts  were determined  24 h  after infection with  approximately  6.5  ×  103 Listeria  and  22 
h  after  adoptive  transfer  of 5  ×  10  r spleen  cells. 
§  Means  _+  SEM  of viable  spleen  counts  of groups  of five mice.  Significance  vs.  normal  or no cell 
controls. 
II  P  <  0.05. 
¶  P  <  0.001. 
TABLE  II 
Adoptive Transfer of Listeria Immunity in Various Mouse Strain Combinations 
Spleen Cell* donor  Log,o viable Listeria per spleen of recipient mice* 
H-2 
H-2  1 
1  S  D  K  hA  I-B  I-C  S  D 
I-A  I-B  I-C  CBA/H  B10.D2  B10.A  C3H.OL 
k kkk k k  d ddd d d  k kkd d d  d ddd k k 
B10.BR  2.41  ±  0.18§'11  4.85  ±  0.17¶  2.10 ±  0.0~[  3.87  ±  0.09** 
k  kkk  k  k 
B10.A  1.99  ±  0.0~l  3.67  --_ 0.13"*  2.29 ±  0.1~[  3.51  ±  0.13"* 
k  kkd  d  d 
B10.D2  5.07 --- 0.14¶  2.67 ± 0.1~1,*$  4.02 ± 0.16"*  NT 
d  ddd  d  d 
No cell controls  5.30  ±  0.17  5.32  ±  0.03  5.01  ±  0.06  4.98  ±  0.08 
* Spleen cell donors were infected with 9.5 x  10  s L. monocytogenes  7 days previous to transfer. 5 x 10  ~  spleen cells were transferred 
to recipients infected with 6 x  103 Listeria 2 h previously. 
$ See Materials and Methods.  Counts were determined 24 h after transfer. 
§ Means ± SEM of groups of three to five mice. Statistical significance of protection as compared with no cell controls. 
]1P <  0.00001. 
¶ Not significant. 
** P  < 0.001. 
*~ Significantly smaller than BIO.A, P  < 0.001. 
B10.A and B10.D2 protect each other considerably less by about 1.5 log,0 (P < 
0.001).  The lesser importance of D-end determinants contributing to protection 
in this model was further emphasized  by the fact that B10.BR  cells conferred 
much less protection (i.e.,  1.1 loglo) to C3H. OL recipients as compared with the 
3.5 loglo protection transferred to B10.A (Table II, Fig. 2). Experiment 1 in Table 
III  suggests  that  in  reactions  traced  to  compatibility  at  the K  end,  the I-A 1358  H-2 RESTRICTION  OF  CELL-MEmATED  IMMUNITY  TO  LISTERIA 
TABLE  Ill 
Protective Capacity of Listeria-Immune  Spleen Cells in Reciprocals of Various H-2 
Region Compatibilities 
H-2  H-2  Log~o 
Donor*  K  1  S  D  Recipients  K  I  S  D  Listeria per  Protection 
I-A  I-B  I-C  I-A  I-B  I-C  spleen 
Exp.  1 
C57BL/6  b  bbb  b  b  B10.A(4R)  k  kbb  b  b  3.77 ±  0.03§.11  1.43 
CBA/H  k  kkk  h  k  B10.A(4R)  k  kbb  b  5  2.86  _+  0.13¶  2.34** 
0  B10.A(4R)  k  kbb  b  b  5.20 _+  0.07 
C57BL]6  b  bbb  b  b  C57BL/6  b  bbb  b  b  2.79  ±  0.2~1  3.06 
0  C57BL/6  b  bbb  b  IJ  5.85  _+  0.17 
CBA/H  k  kkk  k  k  CBA/H  k  kkk  k  k  2.81  +_ 0.15¶  3.13 
0  CBA/H  k  kkk  k  k  5.94  ±  0.11 
Exp.  2 
A.TL  s  kkk  k  d  CBA/H  k  kkk  k  k  3.89 ±  0.07¶  1.76 
CBA/H  k  kkk  k  k  CBA/H  k  kkk  k  k  4.51  +_ 0.1311  1.14 
0  CBA/H  k  kkk  k  k  5.65  +_ 0.05 
A.TL  s  kkk  k  d  SJL  s  sss  s  s  5.29  ±  0.23~S  0.84 
0  SJL  s  sss  s  s  6,13  +-  0.09 
* Donor mice were infected with 6.5 ×  10  ~, exp. 1 and 5.2 x  103, exp. 2, and spleen cells transferred 6 days later. Numbers of spleen 
cells transferred were 5.0  x  107,  exp.  1; 2.8  x  10  ~, exp.  2. 
$ Infection of recipients and determination of viable bacterial counts (see Materials and Methods). Recipients  were infected with 
6.5  x  103 Listeria:  exp.  1, 4.0  ×  103; exp.  2, 5,0  x  103. H-2 compatibility  is underscored. 
§ Means  -+ SEM of groups of three to five mice.  Statistical significance  of protection is a comparison with control mice not given 
cells. 
II P  <  o.ool. 
¶ P  <  0.0ool. 
** Statistically  significantly  greater protection than by C57BL/6, P  <  0.01. 
~S P  <  0.05, 
subregion and K region seem to be crucial. The protective potentials of the two 
(CBA/H  and  C57BL/6)  spleen  cell  populations  studied  are  comparable;  both 
protect syngeneic recipients by about 3.1 loglo. However, CBA/H-immune cells 
conferred  about  2.3  loglo  protection  to K  plus I.A  compatible  recipients  as 
compared with 1.4 loglo transferred by I-B, I-C, S, and D  compatible C57BL/6 
immune cells.  Experiment 2 further suggests that the I-A  subregion  may be 
responsible for most of the protective effect, since A.TL-immune  spleen cells 
protected H-2K compatible SJL mice markedly less than I plus S region compat- 
ible CBA/H mice. Immune T cells from mice possessing the wild type K, I-A, 
and I-B  regions protected H-2K b mutant mice which share the I  region with 
wild-type mice, as well as they protected wild-type recipients (Table IV). These 
results,  unlike  those  involving  virus-specific  cytotoxicity  in  which  H.2K ba 
(Hzl)-immune spleen cells cannot protect wild-type H-2K b recipients in vivo or 
efficiently lyse such cells in vitro or vice versa (30-32),  suggest that compatibil- 
ity at the I region is sufficient for adoptive transfer of immunologic protection 
against Listeria. 
Attempts  to  Separate  T-Cell  Specificities  of F1  Hybrid  Mice  by  Selective 
Proliferation.  With an experimental approach that was originally applied in 
the lymphocytic choriomeningitis virus (LCMV)  system to dissect cytotoxic T- 
cell  specificities in F1  hybrids  (11,  33),  several  attempts were undertaken  to 
evaluate whether the same F1 T cells could protect recipients of  both P strains or 
whether two distinct T-cell populations were specific, one for P1 and the other 
for P2. 
Irradiated parental recipients were infected with Listeria and transfused with ZINKERNAGEL ET AL.  1359 
LISTERIA  RECIPIENT  COMPATIBILITY 
IMMUNE 
DONORS 
H  -2  H  -2 
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FIG. 2.  Adoptively  transferred  anti-Listeria  protection  expressed  as  the  difference  of 
viable bacteria  counts  in spleens of control mice receiving no cells minus the counts  in 
spleens of mice transfused with 7-day immune spleen cells of various H-2 types. From Table 
II. 
F1 7-day immune spleen cells. Irradiation prevents macrophage to proliferate in 
the bone marrow and to reach the  infectious  lesion.  Therefore,  Listeria  grew 
rapidly.  Antibiotic treatment in vivo after 2 days and after spleen cell removal 
at 3 days followed by cultivation of spleen cells in medium containing antibiotics 
for 24 h  eliminated bacteria successfully.  These spleen cells were then assayed 
for  their  protective  potential  in  the  final  recipients  by  using  the  standard 
protocol.  These experiments  were difficult to perform and many intermediate 
recipient mice died of the overwhelming infection. Unfortunately, therefore, the 
double transfers could not be made in all reciprocal permutations, F1 --> PI --> P1, 
F1 ~  P1 -* P2, F1 --* P2 ~  P1 and F1 ~  P2 --* P2. Nevertheless,  in two successful 
experiments  out of four attempts the immune FI cells transferred through P1 
were subsequently able to protect P1 recipients bettter than P2 recipients (Table 
V). The effector cells assessed in these double transfer experiments were T cells 
as shown by their susceptibility to anti-0 treatment  (Table V, exp. 2). The two 
examples to suggest that F1 possess two separate Listeria-immune T-cell spec- 
ificities,  each specific for one parental H-2 haplotype. 
Discussion 
Analysis of the previously described finding (21) that Listeria-immune T cells 
are  H-2  specific  in  their  capacity  to  transfer  immunity  adoptively  to  naive 1360  H-2  RESTRICTION  OF  CELL-MEDIATED  IMMUNITY  TO  LISTERIA 
TABLE IV 
A nti-Listeria Protection of Spleen Cells of Immune 
Mutant Mice 
H-2K ° Wild-type Mice in H-2K b 
H-2  H-2  Log,o 
Donor*  K  1  S  D  Recipients  K  I  S  D  Listeriaper  Protection 
1-A  I-B  I-C  I-A  I-B  I-C  spleen§ 
B10,  b  bbb  b  b  B6-H-2 oa  ba  bbb  b  b  2.92  -+ 0.14].¶  2.12 
B10,A(3R)  b  bbd  d  d  B6.H-2 b~  ba  b bb  b  b  3.27 ±  0.14~1,¶  1,77 
CBA/H  k  hkk  k  k  B6-H-2 ~a  ba  bbb  b  b  4.65 -+ 0.06**  0.39 
0  B6-H-2  ~"  ba  bbb  b  b  5.04 ±  0.13 
B10.  b  bbb  b  b  B6-H-2  ~  bf  bbb  b  b  3.21  ±  0.041,[]  1.85 
B10.A(3R)  b  bbd  d  d  B6-Ho2  ~s  bf  bbb  b  b  3.49 ±  0.24~1,5S  1.57 
CBA/H  k  kkk  k  k  B6-H-2 bl  bf  bbb  b  b  4.69 ±  0.0555  0.37 
0  B6-H-2 by  bf  bbb  b  b  5.06 ±  0.09 
B10.  b  bbb  b  b  C57BL/6  b  bbb  b  b  3.12 ±  0.11~]']]  1.75 
B10.A(3R)  b  bbd  d  d  C57BL/6  b  bbb  b  b  3.44 ±  0.0~['11  1.43 
CBA/H  k  kkk  k  k  C57BL/6  b  bbb  b  b  4.39 ±  0.07**  0.48 
O  C57BL/6  b  bbb  b  b  4.87  ±  0.16 
CBA/H  k  kkk  k  k  CBA/H  k  Md¢  k  k  3.87  ±  0.0~]  1.38 
0  CBA/H  k  hhh  h  h  5.25 ±  0.09 
* Donor mice were infected with 1 ×  104 Listeria  7 days previous to transfer. 
S Recipients were transfused with 5 x  107 spleen cells 2 h after infection with 4.2 x  103L. monoeytogenes.  Determination of  viable 
counts 24 b after transfer, see Materials and Methods. 
§ Means  ±  SEM of groups of three to five mice.  Protection was significant when compared  with control mice not given cell 
transfer (first symbol) or when compared with recipients of allogeneic cells (second  symbol). 
IIP <  0.001. 
¶ P  <  0.01. 
** Not significant. 
55 P  <  0.05. 
TABLE V 
Protective Effect of Listeria-Immune F1 Spleen Cells  Which  Were Selected In Vivo by 
Transfer for 3 Days to Infected P1 Recipients and Thereafter Assayed In P1 or P2 Final 
Recipients for Anti-Listeria Protection* 
Original donor (H-2  Intermediate recipient (H-  Cell treatment  Final recipient  Log]. viable Liste-  ria  in spleen 48 h 
type)  2  type) (850 rad)  (H-2 type)  aRer cell transfers 
Exp,  1 
CBA/H  ×  C57BL/6  F~ 
(h  x  b) 
None 
CBA/H (k)  CBA/H (k)  3.40 ±  0.12§,1t 
C57BL/6 (b)  4.46 ±  0.10 
None  CBA/H (k)  4.63  -+ 0.25 
C57BL/6 (b)  4.87 ±  0.12 
Exp. 2 
CBA/H x  BALB/c F~ (k  CBA/H (k)  CBA/H (k)  2.63 ±  0.071] 
× d)  BALB/c (d)  4.33  ±  0.15 
None  None  CBA]H (k)  5.65  ±  0.07 
BALB/c (d)  5.35 -+ 0.06 
CBA/H × BALB/c Fz (k  CBA/H (k) (2.5 x  107)  AKR anti0 +  C'  CBA/H (k)  5.23  _+  0.11 
× d)  Nor AKR serum  +  C'  CBA/H (k)  3.73  _+ 0.1711 
*  For experimental details see Materials and Methods. 
$ Final recipient mice were infected with about 5.1 x  103 (exp.  1) and 4.0 x  103 (exp.  2) Listeria  2 h previous to cell transfer. Viable 
counts were determined 48 h  later. 
§ Means ±  SEM of three to four recipients. 
II  Significantly smaller than final recipient which is net H-2 compatible with intermediate recipients (P <  0.001). 
recipients revealed that, first, the H-2 restriction of effector T cells is virtually 
absolute under the conditions employed; second, the self-marker recognized is 
probably coded by the/-A  subregion of H-2;  third, in F1 heterozygotes at least 
two separable T-cell specificities exist-one each for Listeria antigen in associa- ZINKERNAGEL ET AL,  1361 
tion with the two respective parental H-2 haplotypes. Thus, the H-2-associated 
specificities of effector T cells generated during virus infections and infections 
with intracellular bacteria differ with respect to the H-2 subregions involved (6, 
7); the effector activity of Listeria-immune spleen cells is specific for anI-region- 
coded structure, which is analogous to the situation for helper T cells (2, 3), in 
contrast to the specificity of cytolytic T cells which exhibit specificity for K or D 
structures. 
The selective proliferation experiments in F1 hybrids suggest strongly that 
the Listeria-immune T cells are H-2I haplotype specific. Such T cells appear to 
be specific either for a  structural complex of self plus Listeria antigen or for 
bacterial antigen that is expressed on the cell surface and which is modified byI- 
region-linked enzymes (34) (altered-self, Fig.  3).  Alternatively, T  cells may 
possess two independently and clonally expressed receptors, one for Listeria 
antigen  and one for the/-region-coded self-structure (dual  recognition); the 
clonality of the expression of the self-recognition structure is suggested by the F1 
experiment (11, 35-37). If one uses the dual recognition model to explain H-2 
restriction, the haplotype specificity ofListeria-immune T cells, suggests allelic 
exclusion of recognition structures for/-coded self-markers. Since/-coded self- 
markers  are  codominantly expressed  on  B  cells  (38), and  possibly  also  on 
macrophages, allelic exclusion of/recognition makes a mutual like-like self- 
interaction model of  I-coded structures an unlikely model to explain H-2 restric- 
tion (2, 6). Therefore, if the findings from virus-specific cytotoxicity models can 
be translated to noncytotoxic/-region-specific  T-cell activity, it is more likely 
that I  restriction reflects unidirectional recognition by T cells of/-coded self- 
markers on target cells (35-39). However, as has been discussed extensively for 
the T helper and the virus models, the available data do not allow one, at the 
moment, to distinguish between the two basic models of T-cell recognition: dual 
recognition or altered-self (2-7,  34-39). 
How can the differential association of various infectious agents with K, D, or 
/-coded structures be  explained? For  the  following discussion  we  make the 
assumptions that,  first,  the  mammalian-immune system is  the  vertebrate's 
solution to combat intracellular infectious agents and,  second, that cell-me- 
diated immunity is the ancient part of the immune system. The relative impor- 
tance of antibodies and T cells in immunity to infection by intracellular bacteria 
or viruses in primary infections need not be discussed here. The current concepts 
have been reviewed recently (40-43). Strong evidence exists in several murine 
infectious disease models that specific effector T cells are generated very rapidly 
after infection, i.e., within 2-4 days; for example, in Listeria (25), pox virus (40) 
or LCMV (R. M. Zinkernagel, unpublished data) infections. Since any means of 
eliminating or decreasing the functional T-cell compartment in mice results in a 
drastic failure to control virus or intracellular bacterial growth during this 2- to 
4-day period after infection, the crucial role of T cells in controlling primary 
infections very early and rapidly is strongly indicated. Nevertheless, one cannot 
fully exclude contributions by pre-existent antibodies that are specific or non- 
specific,  i.e.  cross-reacting, or specific  antibodies generated with T-cell help. 
Immunity in the Listeria model is extreme in its apparent independence from 
antibodies, whereas protection against other intracellular bacteria like Salmo- 1362  1"1-2 RESTRICTION  OF  CELL-MEDIATED  IMMUNITY  TO  LISTERIA 
Dual roco|nition  Sin|le  roco|nition 
FIG.  3. 
2  linked,  independently 
clonuliy  expressed  receptors 
~a,tl$) 
1 clenally  lxprossud  receptor  for 
complex of  la  plus Listeria  Antigen 
or  Listoria  Aotilen  modified  by 
la  determinants 
Models for T-cell recognition of Listeria antigen on macrophage surfaces. 
nella  obviously depends upon specific antibodies in addition to cell-mediated 
immunity (44-46). 
Can the results presented here contribute to a better understanding of effector 
T-cell specificity and a  possible mechanistic role of I  and K  or D  coded self- 
markers? The crucial functional antigenic characteristic of viruses and intra- 
cellular bacteria is that they "hide" behind the cell walls and can propagate 
themselves more or less directly from cell to cell avoiding the circulation and 
extracellular spaces where they could be subject to attack by antibody plus C. 
However, two important points are worth stressing: first, this hiding-away is 
not totally successful since after viral infection, and probably also after intracel- 
lular bacterial infection, foreign specific antigenic determinants are expressed 
on the infected cells; and second, viruses and bacteria differ in their habitats. 
Thus, with differential preferences called "tropisms," viruses can actively infect 
phagocytic or nonphagocytic cells because these cells have the relevant cell 
surface structures allowing viruses to absorb to and penetrate actively into the 
passive cells.  No such mechanism exists for intracellular bacteria,  which,  in 
contrast,  have to be actively phagocytized by cells; this,  in turn,  limits their 
habitat to phagocytic cells. 
If T cells must recognize self-markers in addition to foreign antigens on cell 
surfaces to become sensitized or to mediate effector function, it seems necessary 
that the self-marker involved in cell-mediated immunity against viruses be an 
ubiquitous one. Major transplantation antigens coded in the K  and D regions of 
H-2 exist in varying amounts on virtually all cell surfaces of an individual. In 
contrast, the self-marker involved in cellular immunity to intracellular bacteria 
may be largely restricted to phagocytic cells. 
T-cell-mediated protection against virus infection can occur in several ways; 
the  relative  importance  of one  or  the  other  depends  upon  several  factors, 
particularly the pathogenesis of the virus disease in question and the time after 
infection. Two possible main effector mechanisms are: first,  virus that infects 
cells  causes cell  surface changes very shortly  after penetration,  i.e.,  before 
infectious virus progeny are assembled  (31,  32,  47,  48).  Recent evidence has 
shown that cytotoxic T cells inhibit the amounts of virus produced by target cells 
actively infected with vaccinia virus, and that the degree of inhibition directly 
correlates with the cytolytic activity of such T cells; once infectious progeny are 
assembled,  T  cells cannot directly influence viral  titers  (47). These findings 
indicate that the rapidly generated cytotoxic T cells can therefore control virus ZINKERNAGEL ET AL.  1363 
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FIG. 4.  Models of T-cell-mediated  macrophage activation. Although only the dual recogni- 
tion model for T-cell recognition is depicted, the model is also applicable to the single 
recognition model. In both, antigenic specificity  is given by the Listeria ((~))-specific part of 
recognition and the activation signal is delivered  through the I-region-coded  self-structure 
((~. This could result in direct macrophage  activation resulting in digestion of bacteria. 
Alternatively, the recognition  of Listeria  antigen plus/-coded self-marker could result in 
lymphokine production (~).  Such factors could then  trigger the activation ((~) of 
surrounding ((~) macrophages. 
production and spread by directly destroying infected cells via a cytolytic signal 
before infectious progeny are assembled. Second, T cells may act in a  specific 
anti-viral  manner or by nonspecific mechanisms such as  release of immune 
interferon or  by  lymphocyte-mediated recruitment and  activation  of macro- 
phages to exert increased virucidal activity. Alternatively, specific T cells may 
"activate" macrophages thereby exposing the relevant antigens to  increased 
virucidal activity by direct contact, but via a noncytolytic signal. 
Similarly, it is generally agreed that T-cell-mediated protection against intra- 
cellular bacteria occurs by mechanisms similar to the latter model (43). Accord- 
ingly,  T  cells are either triggered specifically to  release lymphokines which 
nonspecifically recruit and activate macrophages to increased bactericidal ca- 
pacity and/or alternatively, as proposed here,  may activate macrophages ex- 
pressing the relevant foreign and self-surface antigens by direct contact (Fig. 4). 
So far no cytotoxic effector T  cells has been demonstrated in immunity to 
Listeria. This is obviously no strong argument against their existence, and their 
absence may be explained by technical difficulties in obtaining and maintaining 
Listeria-infected  macrophage  target  cells  even  for  limited  periods  of time. 
However, there are good theoretical reasons why cytolytic cell-mediated immu- 
nological interactions may not be crucial in dealing with intracellular bacteria. 
In contrast to viruses, intracellular bacteria (comparable to any inert conven- 
tional antigen or toxins) never lose their anatomical and functional identity. (As 
discussed previously,  for a  brief period  after penetration  during the eclipse 
phase, viruses do not exist as individual infectious entities and, therefore, are 
vulnerable to destruction by host cell lysis.) In the case of bacteria, therefore, 
lysing the host cell never kills the organism, but only results in release of intact 
bacteria. Thus, growth and spreading of Listeria is controlled only when phago- 
cytic cells have acquired the capacity to digest the bacteria efficiently. T cells 
which  recognize  antigen  in  association  with  /-coded  structures  may  send 
through this I structure a noncytolytic, but "activating," signal to the recognized 
phagocytic cell. Alternatively, this/-associated T-cell recognition may trigger 
the T cell itself to release lymphokines, which, in turn, could activate macro- 
phages. 1364  H-2  RESTRICTION OF  CELL-MEDIATED IMMUNITY  TO LISTERIA 
Thus Listeria, a biologically active, infectious agent, elicits a T-cell response 
that has the I  region-associated specificity characteristics of T cells handling 
chemically inert or noninfectious antigens and differs from the H-2K-  and D- 
restricted murine virus models. Based on the considerations discussed above, it 
now appears that K and D regions code for structures where cytolytic  signals can 
be delivered most efficiently  by T cells; in contrast, as suggested previously (2), 
the I region codes for structures where predominantly  noncytolytic  T-cell signals 
that trigger cell-specific differentiation processes can be delivered. Thus, anti- 
gen-specific triggering of a certain/-coded structure on macrophages may, for 
example, result in differentiation  of its digestive enzymes, whereas on certain B 
cells such a signal via another/-coded structure may result in the switch from 
IgM to IgG production. 
Summary 
The protective activity of anti-Listeria-immune T cells assayed in an adoptive 
transfer system is H-2 restricted. As shown in the present studies, the demon- 
stration of the restriction is directly dependent on the dose and the relative 
protective activity of spleen cells. In addition, some H-2-unrestricted protection 
is conferred predominantly by other than immunoglobulin-negative spleen cells. 
Thus,  the activity of Listeria-immune  T  cells appears to be "absolutely" re- 
stricted and is in this respect comparable to in vivo T-cell-mediated anti-viral 
protection. The predominant genetic region of H-2  coding for the structures 
which are mainly involved in this restriction in T-cell immunity to this proto- 
type intracellular bacterium is the I region. The specificity ofListeria-immune T 
cells is determined by the H-2 haplotype of the donor. Thus, F1 hybrids seem to 
possess at least two separable sets of T  cells,  each specific  for one parental 
haplotype. As is true in the virus model, the results cannot distinguish between 
an altered-self or a dual recognition model of T-cell recognition to explain H-2 
restriction.  They  are,  however,  compatible  with  the  idea  that /-coded cell 
surface structures may serve as receptors for cell-specific differentiation signals, 
which trigger  direct  or  lymphokine-mediated activation  of macrophages to 
manifest  increased bactericidal  capacity.  The  interesting  parallels  in  self- 
marker recognition by T cells in the virus and intracellular bacterium systems, 
respectively, appear to be reasonably explained by the different types of signals 
transmitted by T cells to various target cells via the distinctly different self- 
markers employed (i.e., K or D vs. I). 
We thank Dr. F. J. Dixon for continuous support, and Doctors R. E. Langrnan for discussion and 
D. H. Katz for critically reviewing the manuscript. The technical assistance of Miss Susie Barry, 
Miss Pam Murphy, and Miss Cheryl Bogowitz; the secretarial assistance of Ms. Candice LaMar; 
and the editorial assistance of Mrs. Phyllis Minick in preparing the manuscript are also greatly 
acknowledged. 
Received for publication  9 December 1976. 
References 
1.  Zinkernagel, R.  M.  1976. H-2  restriction of virus-specific T-cell-mediated effector 
functions in vivo. II. Adoptive transfer of delayed-type hypersensitivity to murine ZINKERNAGEL  ET AL.  1365 
lymphocytic choriomeningitis virus is restricted by the K  and D  regions of H-2. J. 
Exp. Med.  144:776. 
2.  Katz, D.  H., and B. Benacerraf.  1975. The function and interrelationship of T cell 
receptor  Ir  genes  and  other  histocompatibility  gene  products.  Transplant.  Rev. 
22:175. 
3.  Katz, D. H., M.  G. Graves, M.  E. Doff, H. Dimuzio, and B. Benacerraf.  1975. Cell 
interactions  between  histoincompatible  T  and  B  lymphocytes.  VII.  Cooperative 
responses between lymphocytes are controlled by genes in the I  region of the H-2 
complex. J. Exp. Med.  141:263. 
4.  Miller,  J.  F.  A.  P.,  M.  A.  Vadas,  A.  Whitelaw,  and J.  Gamble.  1975. H-2 gene 
complex restricts transfer of delayed-type hypersensitivity in mice. Proc. Natl. Acad. 
Sci.  U. S. A.  72:5095. 
5.  Zinkernagel, R. M.  1976. T helpers may be sensitized by antigen-specifically altered 
structures  which  are coded by the I  region of the H-2 gene complex. In  Immune 
Reactivity of Lymphocytes. M. Feldman and A. Globerson, editors. Academic Press, 
Inc., New York. 527. 
6.  Doherty, P.  C.,  R.  V.  Blanden,  and R.  M.  Zinkernagel.  1976. Specificity of virus- 
immune effector T cells for H-2K or H-2D compatible interactions: implications for H- 
antigen diversity. Transplant. Rev. 29:89. 
7.  Zinkernagel, R. M., and P. C. Doherty. 1976. Major transplantation antigens, virus 
and specificity of surveillance T cells. Contemp.  Top. Immunobiol.  In press. 
8.  Cantor, H., and E. A. Boyse. 1975. Functional subclasses of T lymphocytes bearing 
different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a 
differentiative process independent of antigen. J. Exp. Med.  141:1376. 
9.  Pang, T., I. F. C. McKenzie, and R. V. Blanden. 1976. Cooperation between mouse T 
cell subpopulations in the cell-mediated response to a  natural pox-virus pathogen. 
Cell. Immunol.  In press. 
10.  Blanden, R. V., T. C. Doherty, M. B. C. Dunlop, I. D. Gardner, R. M. Zinkernagel, 
and C. S. David. 1975. Genes required for cytotoxicity against infected target cells in 
K and D regions of H-2 complex. Nature (Lond.).  254:269. 
11.  Zinkernagel,  R.  M.,  and  P.  C.  Doherty.  1975. H-2  compatibility requirement  for 
virus-specific cytolysis in vitro. II. Different cytotoxic T cell speciflcities are associ- 
ated with structures coded for in H-2K or H-2D. J. Exp. Med.  141:1427. 
12.  Shearer, G. M., T. G. Rehn, and A. Schmitt-Verhulst. 1976. Role of the murine major 
histocompatibility complex in the specificity of in vitro T-cell-mediated lympholysis 
against chemically-modified autologous lymphocytes. Transplant. Rev. 29:222. 
13.  Bevan, M. J. 1975. Interaction of antigens detected by cytotoxic T cells with the major 
histocompatibility complex as modifier. Nature (Lond.).  256:419. 
14.  Gordon, R. D., E. Simpson, and L. E. Samelson. 1975. In vitro cell-mediated immune 
responses to the male-specific (H-Y) antigen in mice. J. Exp. Med.  142:1108. 
15.  Mackaness, G. B. 1962. Cellular resistance to infection. J. Exp. Med.  116:381. 
16.  Mackaness, G. B.  1964. The immunological basis of acquired cellular resistance. J. 
Exp. Med.  120:105. 
17.  Mackaness, G. B. 1969. The influence of immunologically committed lymphoid cells 
on macrophage activity in vitro. J. Exp. Med.  129:973. 
18.  Lane,  F.  C.,  and E.  R.  Unanue.  1972. Requirement of thymus (T)  lymphocyte for 
resistance to listeriosis. J. Exp. Med.  135:1104. 
19.  Blanden,  R.  V.,  and  R.  E.  Langman.  1972. Cell-mediated immunity to bacterial 
infection in the mouse. Thymus derived cells as effectors of acquired resistance to 
Listeria monocytogenes. Scand. J. Immunol.  1:379. 
20.  North, R. J. 1973. Importance of thymus-derived lymphocytes in cell-mediated immu- 
nity to infection. Cell. Immunol.  7:166. 1366  Ho2  RESTRICTION  OF  CELL-MEDIATED  IMMUNITY  TO  LISTERIA 
21.  Zinkernagel, R. M.  1974. Restriction by the H-2 gene complex of the transfer of cell- 
mediated immunity to Listeria monocytogenes. Nature (Lond.).  251:230. 
22.  Mitchison, N. A.  1954. Passive transfer of transplantation immunity. Proc. R. Soc. 
Lond. B Biol. Sci.  142:72. 
23.  Lawrence, H.  S.  1959. Homograft sensitivity. An expression of the immunological 
origins and consequences of individuality. P.hysiol. Rev. 39:811. 
24.  Shreffier, D. C., and C. S. David. 1974. The H-2 major histocompatibility complex and 
the I immune response region: genetic variation, functions and organization. Adv. 
Immunol.  20:125. 
25.  Klein, J. 1975. Biology of the Mouse Histocompatibility 2 Complex. Springer-Verlag 
New York Inc., New York. 
26.  Parish, C. R., S. M. Kirov, N. Bowern, and R. V. Blanden. 1974. A one-step procedure 
for separating mouse T and B lymphocytes. Eur. J. Immunol.  4:808. 
27.  Lafferty, K. J., M. Ryan, and I. S. Misko. 1974. An improved system for the assay of 
stimulation in mouse mixed leukocyte cultures. J. Immunol.  Methods.  4:263. 
28.  Cerottini,  J.  C.,  and  K.  T.  Brunner.  1974. Cell-mediated  cytotoxicity,  allograft 
rejection and tumor immunity. Adv. Immunol.  19:67. 
29.  Zinkernagel, R. M., R. V. Blanden, and R. E. Langman. 1974. Early appearance of 
sensitized lymphocytes in mice infected with Listeria monocytogenes. J. Immunol. 
112:496. 
30.  Kees, U., and R. V. Blanden. 1976. A single genetic element in H-2K affects mouse T- 
cell antiviral function in pox-virus infection. J. Exp. Med.  143:450. 
31.  Zinkernagel, R. M., and R. M. Welsh. 1976. H-2 compatibility requirement for virus 
specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring 
antiviral protection against lymphocytic choriomeningitis virus is associated with H- 
2K and H-2D. J. Immunol.  117:1495. 
32.  Zinkernagel,  R.  M.  1976. H-2  compatibility requirement  for virus-specific T-cell- 
mediated cytolysis. The H-2K structure involved is coded by a single cistron defined 
by H-2K b mutant mice. J. Exp. Med.  143:437. 
33.  Zinkernagel, R. M., and P.  C.  Doherty. 1974. Activity of sensitized thymus derived 
lymphocytes in  lymphocytic choriomeningitis  reflects immunological surveillance 
against altered self components. Nature (Lond.).  251:547. 
34.  Blanden, R. V., A. J. Hapel, and D. C. Jackson. 1976. Mode of action of Ir genes and 
the nature of T cell receptors for antigen. Immunochemistry.  13:179. 
35.  Zinkernagel, R. M.  1976. H-2 restriction of virus-specific cytotoxicity across the H-2 
barrier. Separate effector T-cell specificities are associated with self-H-2 and with the 
tolerated allogeneic H-2 in chimeras. J. Exp. Med.  144:933. 
36.  Doherty,  P.  C.,  D.  GStze, G. Trinchieri,  and R.  M.  Zinkernagel.  1976. Models for 
regulation  of virtually  modified  cells  by  immune  thymus  derived  lymphocytes. 
Immunogenetics.  3:517. 
37.  Zinkernagel, R. M., and P. C. Doherty. 1976. The concept that surveillance of self is 
mediated via the same set of genes that determines recognition of allogeneic cells. 
Cold Spring Harbor Syrup.  Quant. Biol.  59:in press. 
38.  Frelinger, J. A., J. E. Niederhuber, C. S. David, and D. C. Shreffier. 1974. Evidence 
for the expression of Ia (H-2 associated) antigens on thymus-derived lymphocytes. J. 
Exp. Med.  140"1273. 
39.  Davidson,  W.  F., T.  Pang,  R.  V. Blanden,  and P.  C.  Doherty.  1976. Physiological 
interaction  does not explain the  H-2 requirement for recognition of virus-infected 
cells by cytotoxic T cell. Aust. J. Exp. Biol. Med. Sci. In press. 
40.  Blanden, R. V. 1974. T cell response to viral and bacterial infection. Transplant. Rev. 
19:56. ZINKERNAGEL  ET AL.  1367 
41.  Bloom, B. R. and B. Rager-Zisman. 1975. Cell-mediated immunity in viral infections. 
In Viral Immunology and Immunopathology. A. L. Notkins, editor. Academic Press, 
Inc., New York.  113. 
42.  Notkins, A. L. 1975. Interferon as a mediator of cellular immunity in viral infections. 
In Viral Immunology and Immunopathology. A. L. Notkins, editor. Academic Press, 
Inc., New York.  149. 
43.  Blanden,  R.  V., A. J.  Hapel,  P.  C.  Doherty, and R.  M.  Zinkernagel.  Lymphocyte- 
macrophages interactions and macrophage activation in the expression of antimicro- 
bial immunity in vivo. In Immunobiology of the Macrophage. D. S. Nelson, editor. 
Academic Press, Inc., New York. 367. 
44.  Rowley, D., K. J. Turner, and C. R. Jenkin.  1964. The basis for immunity to mouse 
typhoid. III. Cell-bound antibody. Aust. J. Exp. Biol. Med. Sci. 42:237. 
45.  Jenkin,  C. R., and D. Rowley. 1963. Basis for immunity to typhoid in mice and the 
question of"cellular immunity." Bacteriol. Rev. 27:391. 
46.  Collins,  F.  M.  1971. Mechanisms in antimicrobial immunity. J. Reticuloendothel. 
Soc.  10:58. 
47.  Zinkernagel,  R.  M.,  and  A.  Althage.  1977. Antiviral protection by virus-immune 
cytotoxic T  cells:  infected target cells are lysed before infectious virus progeny is 
assembled. J. Exp. Med.  145:644. 
48.  Ada,  G.  A.,  D.  C.  Jackson,  R.  V.  Blanden,  R.  Thahla,  and N.  A.  Bowern.  1976. 
Changes  in  the  surface  of virus-infected  cells  recognized by cytotoxic T  cells.  I. 
Minimal requirements for lysis ofectromelia infected P815 cells. Scand. J. Immunol. 
5:23. 